Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.21019
Abstract: Key Points Question In patients with metabolic dysfunction–associated steatotic liver disease (MASLD), can those at high risk of developing hepatocellular carcinoma (HCC) be identified? Findings This prognostic study used electronic health record data from 1 811 461… read more here.
Keywords: steatotic liver; dysfunction associated; hepatocellular carcinoma; liver disease ... See more keywords
Value-Based Pricing of Resmetirom for Metabolic Dysfunction–Associated Steatotic Liver Disease
Sign Up to like & getrecommendations! Published in 2025 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2025.17122
Abstract: Key Points Question Compared with standard of care, is resmetirom cost-effective in treating metabolic dysfunction–associated steatohepatitis and significant fibrosis among US adults in a simulated cohort? Findings In this economic evaluation, at a price of… read more here.
Keywords: resmetirom; value based; dysfunction associated; metabolic dysfunction ... See more keywords
Effects of Metabolic Dysfunction–Associated Steatohepatitis in Alertness, Associative Learning, and Astrocyte Density
Sign Up to like & getrecommendations! Published in 2024 at "Brain and Behavior"
DOI: 10.1002/brb3.70222
Abstract: Metabolic dysfunction–associated steatohepatitis (MASH) is a prevalent disease caused by high fat and high cholesterol intake, which leads to systemic deterioration. The aim of this research is to conduct a psychobiological exploration of MASH in… read more here.
Keywords: associated steatohepatitis; effects metabolic; dysfunction associated; metabolic dysfunction ... See more keywords
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease
Sign Up to like & getrecommendations! Published in 2024 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.3787
Abstract: Given the increasing number of individuals developing metabolic dysfunction‐associated steatotic liver disease (MASLD) and the low rate of those with progressive liver disease, there is a pressing need to conceive affordable biomarkers to assess MASLD… read more here.
Keywords: dysfunction associated; liver disease; metabolic dysfunction; liver ... See more keywords
Incident heart failure is common and underrecognized in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease.
Sign Up to like & getrecommendations! Published in 2025 at "European journal of heart failure"
DOI: 10.1002/ejhf.3697
Abstract: Metabolic dysfunction‐associated steatotic liver disease (MASLD) is associated with heart failure (HF), independent of shared risk factors. Our aim was to describe the incidence of HF in patients with biopsy‐proven MASLD. read more here.
Keywords: heart; dysfunction associated; heart failure; metabolic dysfunction ... See more keywords
Cardiovascular risk of metabolic-dysfunction-associated steatotic liver disease in Mexican pediatric population.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of pediatric gastroenterology and nutrition"
DOI: 10.1002/jpn3.70287
Abstract: OBJECTIVE This study examines the association between metabolic-dysfunction-associated steatotic liver disease (MASLD) and cardiovascular risk, focusing on the predictive value of anthropometric, metabolic, and hepatic markers. METHODS A predictive cross-sectional study was conducted in children… read more here.
Keywords: dysfunction associated; risk; metabolic dysfunction; associated steatotic ... See more keywords
Metabolic dysfunction associated steatotic liver disease—Clinicians should not underestimate the role of steatosis
Sign Up to like & getrecommendations! Published in 2024 at "United European Gastroenterology Journal"
DOI: 10.1002/ueg2.12520
Abstract: and longitudinally monitor treatment effects of upcoming therapeutic options like the thyroid receptor beta agonist resmetirom which has recently successfully passed phase 3 development. 13 These tools finally should also predict hepatic and cardiovascular endpoints… read more here.
Keywords: steatotic liver; dysfunction associated; disease clinicians; liver disease ... See more keywords
Metabolic Dysfunction‐Associated Steatotic Liver Disease and Pancreatic Disease—A Population‐Based Nationwide Cohort and Sibling‐Controlled Study
Sign Up to like & getrecommendations! Published in 2025 at "United European Gastroenterology Journal"
DOI: 10.1002/ueg2.12761
Abstract: ABSTRACT Introduction Metabolic dysfunction‐associated steatotic liver disease (MASLD) has been linked to pancreatic diseases, but evidence from population‐based studies with liver histology is lacking. Aims and methods In this population‐based cohort including all Swedish adults… read more here.
Keywords: disease; dysfunction associated; population; population based ... See more keywords
Adding salt to foods and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases
Sign Up to like & getrecommendations! Published in 2025 at "European Journal of Nutrition"
DOI: 10.1007/s00394-025-03745-3
Abstract: Adding salt to foods, a novel indicator for studying habitual sodium intake, has been positively associated with multiple diseases and mortality. However, little is known about its association with liver-related disorders. This study aimed to… read more here.
Keywords: dysfunction associated; metabolic dysfunction; liver; adding salt ... See more keywords
Cardiovascular Risk Reduction in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
Sign Up to like & getrecommendations! Published in 2025 at "Current Cardiology Reports"
DOI: 10.1007/s11886-024-02185-5
Abstract: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease, characterized by hepatic steatosis with at least one cardiometabolic risk factor. Patients with MASLD are at increased risk for the occurrence of… read more here.
Keywords: dysfunction associated; risk; metabolic dysfunction; liver ... See more keywords
In Vitro Influence of Specific Bacteroidales Strains on Gut and Liver Health Related to Metabolic Dysfunction-Associated Fatty Liver Disease
Sign Up to like & getrecommendations! Published in 2024 at "Probiotics and Antimicrobial Proteins"
DOI: 10.1007/s12602-024-10219-1
Abstract: Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a major health risk and a serious worldwide issue. MAFLD typically arises from aberrant lipid metabolism, insulin resistance, oxidative stress, and inflammation. However, subjacent causes are multifactorial.… read more here.
Keywords: disease; dysfunction associated; associated fatty; metabolic dysfunction ... See more keywords